Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label safety and tolerability study of Zenhale in persistent asthma
2014-004583-38Phase 3
- Sponsor
- Merck & Co.
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of mometasone in persistent asthma (2 arms), sponsored by Merck & Co. Primary endpoint: Safety endpoints.
02
Drugs
mometasone
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2014-004583-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004583-38.